The correlation of in vitro and in vivo drug dissolution

Oral Drug Absorption: Prediction and Assessment

Volumn , Issue , 2000, Pages 281-305

  Brockmeier, Dierk ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84964086369     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (35)

1. Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biophar-maceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-420.
2. Hirtz J. The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol 1985; 19: 77S-83S.
3. Hirtz J. The absorption window: fact or fiction? Pharm Int 1987; 5: 175-178.
4. Godbillon J, Evard D, Vidon N, Duval M, Schoeller JP, Bernier JJ, Hirtz J. Investigation of drug absorption from the gastrointestinal tract in man, III. Meto-prolol in the colon. Br J Clin Pharmacol 1985; 19: 113S-118S.
5. Staib AH, Loew D, Harder S, Kollath J, Graul EH, Schuster O, Hugemann EH. Theophyllin. Absorption in verschiedenen Darmabschnitten. In: Rietbrock N, Woodcock BG, Staib AH, Loew D, eds. Drug Absorption at Different Regions of the Human Gastro-Intestinal Tract: Methods of Investigation and Results. Wiesbaden: Friedr. Vieweg & Sohn, 1987:53-62.
6. Staib AH, Fuhr U. Drag absorption differences along the gastrointestinal tract in man: detection and relevance for the development of new drug formulations. In: Kuhlmann J, Weihrauch TR, eds. Food-Drug Interactions. New York: W Zuckschwerdt Verlag, 1995:34-56.
7. Gramatté T, El Desoky E, Klotz U. Site-dependent small intestinal absorption of ranitidine. Eur J Clin Pharmacol 1994; 46: 253-259.
8. Gramatté T. Die Lokalisationsabhängigkeit der Arzneistoffresorption im Dünndarm des Menschen. Dissertation Habilitation, Universität, Dresden, Germany, 1995.
9. Lennernäs H, Ahrenstedt O, Hallgren R, Knutson L, Ryde M, Paalzow LK. Regional jejunal perfusion, a new in vivo approach to study oral drag absorption in man. Pharm Res 1992; 9: 1243-1251.
10. Lennernäs H, Fagerholm U, Raab Y, Gerdin B, Hallgren R. Regional rectal perfusion: a new in vivo approach to study rectal drug absorption in man. Pharm Res 1995; 12: 426-432.
11. Lennernäs H. Does fluid flow across the intestinal mucosa affect quantitative oral drag absorption? Is it time for a reevaluation? Pharm Res 1995; 12: 1573-1582.
12. Brockmeier D. Analyse der Zeitabhängigkeit der Resorption von Arzneistoffen aus dem Gastrointestinaltrakt durch in vitro in vivo Korrelation der Arzneistofffreisetzung. Habilitation Dissertation, Justus-Liebig-Universität, Glessen, Germany, 1990.
13. Brockmeier D. Comparison of in vitro and in vivo dissolution for the study of colonic drug absorption. In: Bieck PR, ed. Colonic Drug Absorption and Metabolism. New York: Marcel Dekker, 1993:109-135.
14. Brockmeier D, von Hattingberg HM. Mean residence time. Methods Find Exp Clin Pharmacol 1986; 8: 309-312.
15. Brockmeier D. In vitro/in vivo correlation of dissolution using moments of dissolution and transit times. Acta Pharm Technol 1986; 32: 164-174.
16. von Hattingberg HM, Brockmeier D. A concept for the assessment of bioavailability in complex systems in terms of amounts and rates. In: Bozler G, van Rossum JM, eds. Pharmacokinetics During Drug Development: Data Analysis and Evaluation Techniques. New York: Gustav Fischer Verlag, 1982:315-323.
17. von Hattingberg HM, Brockmeier D, Voegele D. A method for in vivo-in vitro correlation using the additivity of mean times in biopharmaceutical models. In: Rietbrock N, Woodcock BG, Neuhaus G, eds. Methods in Clinical Pharmacology. Wiesbaden: Friedr. Vieweg & Sohn, 1980:85-93.
18. Voegele D, von Hattingberg HM, Brockmeier D. Ein einfaches Verfahren zur Ermittlung von in vitro in vivo Zusammenhängen in der Galenik. Acta Pharm Technol 1981; 27: 115-120.
19. Tanigawara Y, Yamaoka K, Nakagawa T, Uno T. Correlation between in vivo mean dissolution time and in vitro mean dissolution time of ampicillin products. J Pharmacodyn 1982; 5: 370-372.
20. Möller H, Langenbucher F. In vitro and in vivo dissolution of some sustained release tablets of theophylline. Pharm Ind 1982; 44: 3-8.
21. Nicklasson M, Ellstrom K, Sjoqvist R, Sjovall J. Linear system analysis and moment analysis in the evaluation of bacampicillin bioavailability from microcapsule suspensions. J Pharmacokinet Biopharm 1984; 12: 467-478.
22. Graffner C, Nicklasson M, Lindgren JE. Correlation between in vitro dissolution rate and bioavailability of alaproclate tablets. J Pharmacokinet Biopharm 1984; 12: 367-380.
23. Zerbe H, Luckow V, Cawello W, Cordes G. Isosorbide-5-nitrate sustained-release pellets-an example of computer-supported drug development. Pharm Res 1985; 1: 30-36.
24. Huhuenin RN, Zullinger HW, Niederer R. In vitro in vivo correlation exemplified by sustained release formulations of suprofen. Arzneimittelforsch 1988; 38: 305-308.
25. Drewe J, Guitard P. In vitro in vivo correlation for modified release formulations. J Pharm Sci 1993; 82: 132-137.
26. von Hattingberg HM, Brockmeier D, Voegele D. Moment-Analyse und in vitro-in vivo-Korrelation. Acta Pharm Technol 1984; 30: 93-101.
27. Brockmeier D, von Hattingberg HM. In vitro-in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. Arzneimittelforsch 1982; 32: 248-251.
28. Levy G. Effect of dosage form on drug absorption. A frequent variable in clinical pharmacology. Arch Int Pharmacodyn 1964; 152: 59-68.
29. FDA Guidance for Industry. Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations. 1997.
30. Brockmeier D, Dengler HJ, Voegele D. In vitro-in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example. Eur J Clin Pharmacol 1985; 28: 291-300.
31. Brockmeier D, Voegele D, von Hattingberg HM. In vitro-in vivo correlation, a time scaling problem? Basic techniques for testing equivalence. Arzneimittelforsch 1983; 33: 598-601.
32. Brockmeier D, Grigoleit HG, Leonhardt H. The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur J Clin Pharmacol 1986; 30: 79-82.
33. Brockmeier D, Grigoleit HG, Heptner H, Meyer BH. Kinetics of piretanide absorption from the gastro-intestinal tract. Methods Find Exp Clin Pharmacol 1986; 8: 731-739.
34. Bode H. Biopharmazeutische Charakterisierung von Nifedipin Retardformulierungen. Dissertation, Friedrich-Wilhelm-Universität, Bonn, Germany, 1996.
35. 12 C-nifedipine. Eur J Clin Pharmacol 1996; 50: 195-201.